These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

152 related articles for article (PubMed ID: 10502431)

  • 1. Altered expression of CD44 and variant isoforms in human adenocarcinoma of the endocervix during progression.
    Lu D; Tawfik O; Pantazis C; Hobart W; Chapman J; Iczkowski K
    Gynecol Oncol; 1999 Oct; 75(1):84-90. PubMed ID: 10502431
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Endocervical cancer is associated with an increase in the ligands and receptors for transforming growth factor-beta and a contrasting decrease in p27(Kip1).
    Farley J; Gray K; Nycum L; Prentice M; Birrer MJ; Jakowlew SB
    Gynecol Oncol; 2000 Aug; 78(2):113-22. PubMed ID: 10926789
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Expression of CD44 splice variants in normal, dysplastic, and neoplastic cervical epithelium.
    Woerner SM; Givehchian M; Dürst M; Schneider A; Costa S; Melsheimer P; Lacroix J; Zöller M; Doeberitz MK
    Clin Cancer Res; 1995 Oct; 1(10):1125-32. PubMed ID: 9815903
    [TBL] [Abstract][Full Text] [Related]  

  • 4. CD44 and its v6 spliced variant in lung carcinomas: relation to NCAM, CEA, EMA and UP1 and prognostic significance.
    Nguyen VN; Mirejovský T; Melinová L; Mandys V
    Neoplasma; 2000; 47(6):400-8. PubMed ID: 11263866
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Distribution of epithelial-specific antigen in uterine cervix with endocervical glandular dysplasia.
    Umezaki K; Sanezumi M; Okada H; Okamura A; Tsubra A; Kanazaki H
    Gynecol Oncol; 1997 Sep; 66(3):393-8. PubMed ID: 9299251
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Quantitative assessment of expression of cell adhesion molecule (CD44) splice variants: CD44 standard (CD44s) and v5, v6 isoforms in oral leukoplakias: an immunohistochemical study.
    Godge PY; Poonja LS
    Indian J Dent Res; 2011; 22(3):493-4. PubMed ID: 22048598
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Expression of CD44 in uterine cervical squamous neoplasia: a predictor of microinvasion?
    Callagy G; O'Grady A; Butler D; Leader M; Kay E
    Gynecol Oncol; 2000 Jan; 76(1):73-9. PubMed ID: 10620445
    [TBL] [Abstract][Full Text] [Related]  

  • 8. CD44 expression in sinonasal melanomas: is loss of isoform expression associated with advanced tumour stage?
    Regauer S; Ott A; Berghold A; Beham A
    J Pathol; 1999 Jan; 187(2):184-90. PubMed ID: 10365093
    [TBL] [Abstract][Full Text] [Related]  

  • 9. CD44 Expression in Benign and Neoplastic Human Prostates.
    Dhir R; Gau JT; Krill D; Bastacky S; Bahnson RR; Cooper DL; Becich MJ
    Mol Diagn; 1997 Sep; 2(3):197-204. PubMed ID: 10462610
    [TBL] [Abstract][Full Text] [Related]  

  • 10. CD44 expression is associated with increased survival in node-negative invasive breast carcinoma.
    Diaz LK; Zhou X; Wright ET; Cristofanilli M; Smith T; Yang Y; Sneige N; Sahin A; Gilcrease MZ
    Clin Cancer Res; 2005 May; 11(9):3309-14. PubMed ID: 15867228
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Mammaglobin expression in the female genital tract: immunohistochemical analysis in benign and neoplastic endocervix and endometrium.
    Onuma K; Dabbs DJ; Bhargava R
    Int J Gynecol Pathol; 2008 Jul; 27(3):418-25. PubMed ID: 18580321
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Expression of E-cadherin, beta-catenin, CD44s and CD44v6 in gastric adenocarcinoma: relationship with lymph node metastasis.
    Joo M; Lee HK; Kang YK
    Anticancer Res; 2003; 23(2B):1581-8. PubMed ID: 12820426
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Gains and losses of adhesion molecules (CD44, E-cadherin, and beta-catenin) during oral carcinogenesis and tumour progression.
    Bánkfalvi A; Krassort M; Buchwalow IB; Végh A; Felszeghy E; Piffkó J
    J Pathol; 2002 Nov; 198(3):343-51. PubMed ID: 12375267
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of CD44 in duct cell carcinomas and in intraductal neoplasms of the pancreas.
    Satoh K; Shimosegawa T; Koizumi M; Toyota T
    Anticancer Res; 1997; 17(1A):215-9. PubMed ID: 9066654
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Expression of CD44 splice variants in normal respiratory epithelium and bronchial carcinomas: no evidence for altered CD44 splicing in metastasis.
    Givehchian M; Woerner SM; Lacroix J; Zöller M; Drings P; Becker H; Kayser K; Ridder R; von Knebel Doeberitz M
    Oncogene; 1996 Mar; 12(5):1137-44. PubMed ID: 8649806
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Expression of hyaluronic acid and its receptors, CD44s and CD44v6, in normal, hyperplastic, and neoplastic endometrium.
    Afify AM; Craig S; Paulino AF; Stern R
    Ann Diagn Pathol; 2005 Dec; 9(6):312-8. PubMed ID: 16308159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Overexpression of CD44 variants 6 and 7 in human endometrial cancer.
    Katsura M; Furumoto H; Nishimura M; Kamada M; Aono T
    Gynecol Oncol; 1998 Nov; 71(2):185-9. PubMed ID: 9826458
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Prostate cancer overexpresses CD44 variants 7-9 at the messenger RNA and protein level.
    Iczkowski KA; Bai S; Pantazis CG
    Anticancer Res; 2003; 23(4):3129-40. PubMed ID: 12926045
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Preferential overexpression of CD44v5 in advanced gastric carcinoma Goseki grades I and III.
    Stachura J; Krzeszowiak A; Popiela T; Urbańczyk K; Pituch-Noworolska A; Wieckiewicz J; Zembala M
    Pol J Pathol; 1999; 50(3):155-61. PubMed ID: 10624117
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Markers of stromal invasion during background and precancerous changes of the glandular epithelium and in adenocarcinoma of the cervix uteri].
    Danilova NV; Andreeva IuIu; Zavalishina LÉ; Mal'kov PG
    Arkh Patol; 2012; 74(4):28-33. PubMed ID: 22997952
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.